RU2000132874A - METHOD FOR PREVENTION OF ISCHEMIC HEART DISEASE - Google Patents

METHOD FOR PREVENTION OF ISCHEMIC HEART DISEASE

Info

Publication number
RU2000132874A
RU2000132874A RU2000132874/14A RU2000132874A RU2000132874A RU 2000132874 A RU2000132874 A RU 2000132874A RU 2000132874/14 A RU2000132874/14 A RU 2000132874/14A RU 2000132874 A RU2000132874 A RU 2000132874A RU 2000132874 A RU2000132874 A RU 2000132874A
Authority
RU
Russia
Prior art keywords
prevention
heart disease
ischemic heart
estradiol
months
Prior art date
Application number
RU2000132874/14A
Other languages
Russian (ru)
Inventor
Галина Всеволодовна Чижова
Татьяна Федотовна Алтухова
Original Assignee
Дальневосточный государственный медицинский университет
Filing date
Publication date
Application filed by Дальневосточный государственный медицинский университет filed Critical Дальневосточный государственный медицинский университет
Publication of RU2000132874A publication Critical patent/RU2000132874A/en

Links

Claims (1)

Способ профилактики ишемической болезни сердца у женщин в хирургической постменопаузе, заключающийся в пероральном приеме эстрадиола, отличающийся тем, что назначают дозу 1 мг/сут в течение 12-18 мес.A method for the prevention of coronary heart disease in postmenopausal women, which consists in the oral administration of estradiol, characterized in that a dose of 1 mg / day is prescribed for 12-18 months.
RU2000132874/14A 2000-12-26 METHOD FOR PREVENTION OF ISCHEMIC HEART DISEASE RU2000132874A (en)

Publications (1)

Publication Number Publication Date
RU2000132874A true RU2000132874A (en) 2002-10-27

Family

ID=

Similar Documents

Publication Publication Date Title
NO2017047I1 (en) Tofacitinib, optionally in the form of a pharmaceutically acceptable salt, including citrate salt
FR2678169B1 (en) NOVEL PHARMACEUTICAL COMPOSITIONS COMPRISING A CYCLOSPORIN, FOR ORAL ADMINISTRATION.
DK1169024T3 (en) Pregelatinized starch in a controlled release formulation
NO2013004I2 (en) Axitinib, optionally in the form of a pharmaceutical accentible salt
ATE320799T1 (en) SUSTAINED-RELEASE, ORAL, PHARMACEUTICAL DOSAGE FORMS WITH TRAMADOL
BR0015188A (en) Pharmaceutical compositions
DK1183014T3 (en) Flavored controlled release oral pharmaceutical compositions
CA2131350A1 (en) Sustained release drug formulation containing a tramadol salt
DE60102590D1 (en) PHARMACEUTICAL FORMS FOR TREATING ORAL MYCOSIS
AP2003002763A0 (en) Controlled release formulations for oral administration
ATE252377T1 (en) CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING TILIDINE MESYLATE AS THE ACTIVE INGREDIENT
ZA200308221B (en) Pharmaceutical compositions for oral and topical administration.
CA2354039A1 (en) Pharmaceutical formulations in hydroxypropylmethylcellulose capsules
RU2000132874A (en) METHOD FOR PREVENTION OF ISCHEMIC HEART DISEASE
SE0001916D0 (en) Novel formulation
DZ3050A1 (en) Polymorphic forms of a crystalline azobicydoÄ2,2,2Ü-octane-3-amine citrate and their pharmaceutical compositions.
DZ3103A1 (en) New substituted pyrazolo Ä4,3-EÜdiazepines, pharmaceutical compositions containing them, use as medicament and processes for their preparation.
RU2004112422A (en) ROUVASTATIN IN PREDEDENTIONAL CONDITIONS
JP2003523385A5 (en)
JP2003501387A5 (en)
RU97119670A (en) METHOD FOR PREVENTION OF IKSODIC tick-borne borreliosis
RU97106927A (en) METHOD FOR PREVENTION OF COMPLICATIONS IN CARDIOSURGICAL PATIENTS WITH CHRONIC SEPTIC ENDOCARDITIS
RU2001126021A (en) A method of treating liver diseases
RU97118477A (en) APPLICATION OF RALOXIFEN OR ITS PHARMACEUTICALLY ACCEPTABLE SALT IN PREVENTION OF BREAST CANCER
RU99124298A (en) METHOD FOR CORRECTION OF HEMACOAGULATION DISORDERS IN PREGNANCY PREGNANCY